Clinical Trial Update: Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases [Phase 1]

View source ↗

Summary

This update provides safety assessment information from a Phase 1 study of TK006 given repeatedly to patients with metastatic breast cancer to bone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TK006

Snippet

Sponsor: Jiangsu T-Mab Biopharma Co.,Ltd | Conditions: Breast Cancer | Phase 1 | Status: UNKNOWN